Martin J. Bonick's most recent trade in Ardent Health Partners Inc was a trade of 134,615 Common Stock done . Disclosure was reported to the exchange on March 31, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ardent Health Partners Inc | Martin J. Bonick | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 134,615 | 1,437,937 | - | 0 | Common Stock | |
| Ardent Health Partners Inc | Martin J. Bonick | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.67 per share. | 31 Mar 2026 | 10,952 | 1,303,322 | - | 8.7 | 94,954 | Common Stock |
| Ardent Health Partners Inc | Martin J. Bonick | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.56 per share. | 31 Mar 2026 | 8,026 | 1,314,274 | - | 8.6 | 68,703 | Common Stock |
| Ardent Health Partners Inc | Martin J. Bonick | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2026 | 195,316 | 1,322,300 | - | 0 | Common Stock | |
| Ardent Health Partners Inc | Martin J. Bonick | Director, President and CEO | 31 Mar 2025 | 134,927 | 1,126,984 | - | 0 | Common Stock | ||
| Ardent Health Partners Inc | Martin J. Bonick | Director, President and CEO | 31 Mar 2025 | 12,970 | 992,057 | - | 13.8 | 178,338 | Common Stock | |
| Ardent Health Partners Inc | Martin J. Bonick | Director, President and CEO | 18 Jul 2024 | 98,881 | 1,005,027 | - | 0 | Common Stock |